SANOFI-AVENTIS
Patent Owner
Stats
- 112 US PATENTS IN FORCE
- 1 US APPLICATIONS PENDING
- Sep 28, 2017 most recent publication
Details
- 112 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 5,178 Total Citation Count
- Oct 21, 1981 Earliest Filing
- 399 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
8800759 Bushing for receiving a dropper neck, and corresponding package and kitJun 28, 13Aug 12, 14[B65D]
8801056 Motor vehicle front or rear assembly comprising an element for fastening trim elements to the body shell of the vehicleOct 12, 11Aug 12, 14[B60R]
8680096 Diphenyl-pyrazolopyridine derivatives, preparation thereof, and use thereof as nuclear receptor not modulatorsDec 03, 10Mar 25, 14[A61K, C07D, A61P]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2017/0273,936 USE OF DRONEDARONE FOR THE PREPARATION OF A MEDICAMENT FOR USE IN THE PREVENTION OF CARDIOVASCULAR HOSPITALIZATION OR OF MORTALITYAbandonedNov 09, 16Sep 28, 17[A61K]
2013/0203,651 PHARMACEUTICAL COMPOSITION FOR TREATING A METABOLIC SYNDROMEAbandonedJan 21, 11Aug 08, 13[A61K]
2012/0282,710 LIGAND BINDING DOMAINS OF NUCLEAR RECEPTORS IN CONTROLLABLE FORM AND METHODS INVOLVING THE SAMEAbandonedJul 17, 12Nov 08, 12[G01N]
2012/0122,923 DUAL MOLECULES CONTAINING A PEROXIDE DERIVATIVE, THEIR SYNTHESIS AND THERAPEUTIC USESAbandonedDec 11, 08May 17, 12[A61K, C07D, A61P]
2012/0108,464 TEST SYSTEMS, METHODS AND USES INVOLVING AS160 PROTEINAbandonedJan 27, 10May 03, 12[C12Q, C12N, G01N, C40B]
2012/0094,986 ANTICANCER DERIVIATIVES, PREPARATION THEREOF, AND THERAPEUTIC USE THEREOFAbandonedMar 22, 10Apr 19, 12[A61K, C07D, A61P]
2012/0065,153 AZASUGAR DERIVATIVES, HEPARANASE INHIBITORS, METHOD FOR PREPARING SAME, COMPOSITIONS CONTAINING SAME, USE THEREOFAbandonedSep 08, 11Mar 15, 12[A61K, C07H, A61P]
2012/0004,207 THERAPEUTIC USES OF DERIVATIVES OF PIPERIDINYL-AND PIPERIDINYL-ALKYL CARBAMATESAbandonedSep 09, 11Jan 05, 12[A61K, C07D, A61P]
8088797 -pyrazol-3-yl)methylamine derivatives, preparation thereof and therapeutic use thereofExpiredJun 24, 09Jan 03, 12[A01N]
2011/0312,934 2-ALKYL-6-CYCLOAMINO-3-(PYRIDIN-4-YL)IMIDAZO[1,2-B]-PYRIDAZINE DERIVATIVES, PREPARATION THEREOF, AND THERAPEUTIC APPLICATION THEREOFAbandonedAug 12, 09Dec 22, 11[A61K, C07D, A61P]
8080547 Triazolopyridine carboxamide derivatives and triazolopyrimidine carboxamide derivatives, preparation thereof and therapeutic use thereofExpiredOct 06, 09Dec 20, 11[A61K, C07D]
8071297 Method for the diagnosis and treatment of cardiovascular diseasesExpiredNov 23, 06Dec 06, 11[C07H, C12Q, C12P]
8071601 Aminoquinoline derivatives and their use as adenosine A3 ligandsExpiredJan 18, 11Dec 06, 11[A61K, C07D]
8063045 Fluoropyrrolidines having dipeptidyl peptidase enzyme inhibitory activityExpiredFeb 01, 10Nov 22, 11[A61K, C07D]
8063061 6-heteroarylpyridoindolone derivatives, their preparation and therapeutic use thereofExpiredApr 09, 08Nov 22, 11[A61K, C07D]
8044078 Amino-alkyl amide derivatives as CCR3 receptor ligandsExpiredMar 19, 08Oct 25, 11[A61K, C07D, C07C, A61P]
2011/0257,021 USE OF THE MST PROTEIN FOR THE TREATMENT OF A THROMBOEMBOLIC DISORDERAbandonedApr 28, 11Oct 20, 11[C40B]
2011/0257,392 INTERMEDIATE COMPOUND FOR SYNTHESIZING PHARMACEUTICAL AGENT AND PRODUCTION METHOD THEREOFAbandonedJun 27, 11Oct 20, 11[C07D]
2011/0251,194 ANTINEOPLASTIC DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOFAbandonedJan 07, 11Oct 13, 11[A61K, C07D, A61P]
2011/0251,385 INTERMEDIATE COMPOUND FOR SYNTHESIZING PHARMACEUTICAL AGENT AND PRODUCTION METHOD THEREOFAbandonedJun 27, 11Oct 13, 11[C07D]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.